2011 Outstanding Cancer Research Fellow - Dr Alexander Swarbrick

Dr Alexander Swarbrick and his team at the Garvan Institute of Medical Research have discovered that some cancers actually make a tumour suppressing gene inactive by producing an inhibitor, thereby allowing mutant cells to multiply, spread and form cancers.

His research is looking closely at these inhibitors known as microRNA. They believe understanding its behaviour can be a powerful tool for predicting patient prognosis and may even be a new target for therapy of some cancers.

Category:

Science & Technology

Tags:

• Cancer
• research
• award
• NSW
• gene
• cells
• microRNA
• inhibitor
• prognosis
• therapy